Medytox, South Korea’s leading producer of botulinum toxin products, set up a joint venture firm MedyCeles with Celeste (Thailand) Co Ltd to strengthen its business in Southeast Asia, according to a report in The Korea Herald, last week.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
